HU begins human trial for promising treatment to reverse paralysis and language disorder after stroke
Hiroshima University started the human trial for a promising treatment that offers hope in potentially reversing paralysis and language disorder after moderate to severe stroke using therapeutically superior mesenchymal stem cells (MSCs) derived from the cranial bone.
Takafumi Mitsuhara Emily Henderson Environmental Adaptation Sciences Co Ltd Department Of Neurosurgery Professor Nobutaka Horie Hiroshima University Mesenchymal
Source: news-medical.net